86790

Antibody; virus, not elsewhere specified

CPT code 86790 is a vital diagnostic reporting tool utilized in clinical pathology and immunology to identify the presence of specific antibodies directed against a viral pathogen for which no distinct, dedicated Current Procedural Terminology (CPT) code exists. The human immune system produces specific immunoglobulins, primarily Immunoglobulin M (IgM) and Immunoglobulin G (IgG), in response to viral antigens. IgM antibodies typically emerge during the acute phase of an infection, serving as markers of recent or active exposure, whereas IgG antibodies usually develop later, indicating past infection, convalescence, or established immunity. The laboratory methodology employed under this code encompasses a variety of immunoassays, such as Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence Assay (IFA), Chemiluminescence Immunoassay (CLIA), Western blot, or viral neutralization assays. When a clinician suspects a patient is infected with a rare, emerging, or geographically restricted virus (such as certain arboviruses, arenaviruses, or newly identified strains of known viral families) and requires serological confirmation, blood is drawn and sent to the laboratory. Upon receipt, the laboratory personnel process the specimen, separating the serum from the whole blood via centrifugation. The serum is then introduced to an assay containing the specific viral antigens in question. If the patient has antibodies against this specific virus, they will bind to the antigens. A secondary, enzyme-linked or fluorescently tagged antibody is then introduced to detect the antigen-antibody complexes. The resulting signal is quantified and analyzed to provide a qualitative (positive or negative), semi-quantitative (titer), or quantitative result. Accurate utilization of CPT 86790 requires stringent adherence to coding guidelines; it must strictly be used as a fallback when no specific code is available in the CPT manual. Clinicians and billing personnel must ensure that the specific virus being tested is clearly documented in the patient's medical record and on the claim form, as payers frequently require this information to justify medical necessity and process reimbursement correctly. As new viral pathogens emerge and testing becomes more common, the American Medical Association (AMA) often subsequently issues specific CPT codes, transitioning tests previously billed under 86790 to their own unique designations. Therefore, annual review of the CPT manual is imperative to ensure that a newly established code has not superseded the use of 86790 for a particular viral agent.

Clinical Indications

  • Suspicion of an emerging viral pathogen currently lacking a dedicated CPT code.
  • Clinical evaluation of rare or geographically isolated arboviruses (e.g., Powassan virus, Heartland virus).
  • Assessment of immune status following suspected occupational exposure to a rare viral agent.
  • Investigating a viral syndrome of unknown etiology where specific viral testing has been exhausted or is unavailable.
  • Serological testing for rare hemorrhagic fever viruses during post-travel evaluation.
  • Testing for localized viral outbreaks before public health entities or the AMA designate a specific diagnostic code.

Procedure Steps

  1. Collection of a venous blood sample from the patient using standard phlebotomy techniques.
  2. Transport of the blood specimen to the laboratory under appropriate temperature and biohazard controls.
  3. Centrifugation of the whole blood specimen to isolate the serum or plasma required for the immunoassay.
  4. Preparation of the testing platform, loading specific, rare viral antigens onto microtiter plates or assay slides.
  5. Incubation of the patient's serum with the viral antigens to allow potential antibodies to form antigen-antibody complexes.
  6. Washing the platform with a buffer solution to remove unbound non-specific proteins and non-target antibodies.
  7. Addition of a secondary, labeled conjugate antibody (e.g., anti-human IgG or IgM) that binds to the complexes.
  8. Measurement of the reaction using a spectrophotometer, fluorometer, or equivalent analytical instrument.
  9. Validation of the assay run against established positive and negative controls to ensure accuracy.
  10. Interpretation of the signal intensity to determine qualitative or quantitative results and generation of the final laboratory report.

Coding Guidelines

  • Verify that no specific CPT code exists for the particular viral antibody being tested before assigning 86790.
  • When billing 86790, append a clear narrative or documentation in Box 19 of the CMS-1500 form identifying the exact virus being tested.
  • If testing for multiple distinct 'not elsewhere specified' viruses on the same date of service, report 86790 multiple times and append modifier 59 (Distinct Procedural Service) to subsequent lines.
  • Do not use 86790 for molecular testing (e.g., PCR); this code is exclusively for serological antibody testing.
  • If distinct methodologies are used to test for both IgG and IgM for the same unspecified virus, report the code twice, typically using modifier 59 on the second unit.
  • Regularly check CPT updates, as tests previously billed under 86790 may receive dedicated codes in subsequent updates.

Associated ICD-10 Codes